Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

France Lengthens Interval Between Two COVID-19 Jab Doses to Speed Up Vaccine Campaign

04/12/2021 | 01:28am EDT


ę MT Newswires 2021
All news about BIONTECH SE
09:51aBIONTECHá : Berenberg Bank Adjusts BioNTech Price Target to $235 From $130 on Po..
MT
09:50aBIONTECHá : JPMorgan Adjusts Price Target for BioNTech SE to $133 From $104, Mai..
MT
09:49aBIONTECHá : SVB Leerink Adjusts Price Target on BioNTech to $159 From $118, Main..
MT
07:57aPFIZERá : BioNTech Receive FDA Emergency Use Approval to Broaden COVID-19 Vaccin..
MT
07:37aBIONTECHá : Bryan Garnier Downgrades BioNTech SE to Neutral From Buy, Adjusts Pr..
MT
04:53aBIONTECHá : Says European Medicines Agency Reviewing Data to Expand COVID-19 Use..
MT
04:43aBioNTech to Set Up Regional Headquarters, Production Facility in Singapore
MT
04:24aPRESS RELEASEá : AMSilk raises EUR 29M to accelerate commercialization of its hi..
DJ
03:36aPFIZERá : BioNTech COVID-19 Shot Gets FDA Nod for Emergency Use in Adolescents
MT
03:02aPRESS RELEASEá : MIG portfolio company AMSilk completes EUR29 million financing ..
DJ
More news
Financials
Sales 2021 10 608 M 12 889 M 12 889 M
Net income 2021 6 617 M 8 040 M 8 040 M
Net cash 2021 6 582 M 7 997 M 7 997 M
P/E ratio 2021 6,19x
Yield 2021 -
Capitalization 40 263 M 48 872 M 48 921 M
EV / Sales 2021 3,18x
EV / Sales 2022 4,01x
Nbr of Employees 1 941
Free-Float 87,3%
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Average target price 119,44 €
Last Close Price 166,71 €
Spread / Highest target 5,13%
Spread / Average Target -28,4%
Spread / Lowest Target -45,2%
EPS Revisions
Managers and Directors
NameTitle
Ugur Sahin Chief Executive Officer
Sierk P÷tting Chief Operating & Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Ízlem TŘreci Chief Medical Officer
Christoph Huber Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
BIONTECH SE148.22%48 872
GILEAD SCIENCES, INC.14.21%84 632
WUXI APPTEC CO., LTD.6.21%55 607
VERTEX PHARMACEUTICALS-9.92%55 113
REGENERON PHARMACEUTICALS2.82%52 020
BEIGENE, LTD.17.39%27 943